1. The 3,4-dihydroquinoxalin-2-one system has not been explicitly reviewed previously, but is treated in reviews of quinoxalines. Mamedov, V. A.; Zhukova, N. A. In Progress in Heterocyclic Chemistry; Gribble, G. W.; Joule, J. A., Eds.; Elsevier, 2013, Vol. 25, p. 1.
2. Ramli, Y.; Benzeid, H.; Bouhfid, R.; Kandri Rodi, Y.; Ferfra, S.; Essassi, E. M. Stud. Cercet. Stiint. CICBIA 2010, 11, 1.
3. Gupta, D.; Ghosh, N. N.; Chandra, R. Bioorg. Med. Chem. Lett. 2005, 15, 1019.
4. Matsumoto, Y.; Tsuzuki, R.; Matsuhisa, A.; Yoden, T.; Yamagiwa, Y.; Yanagisawa, I.; Shibanuma, T.; Nohira, H. Bioorg. Med. Chem. 2000, 8, 393.
5. Miyashiro, J.; Woods, K. W.; Park, C. H.; Liu, X.; Shi, Y.; Johnson, E. F.; Bouska, J. J.; Olson, A. M.; Luo, Y.; Fry, E. H.; Giranda, V. L.; Penning, T. D. Bioorg. Med. Chem. Lett. 2009, 19, 4050.